future of glp 1 GLP1 agonists: current and landscape clinical trials for patients with metabolic dysfunction The Future of GLP-1 Therapies:

You are going to see new brands, new products, new industries form around this ecosystem that this drug is already creating. The percentage of households with a GLP-1 user had already doubled from January 2025 to May 2026, per PwC

Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )

Because if these are covered drugs, the state cant just decide whether it wants to cover a particular drug or not

HR, 0.78

Potential Benefits for Lifters and Athletes For those who train, allulose might offer glycogen-sparing effects , helping preserve energy stores during workouts

The SELECT trial included participants with established cardiovascular disease, many in their 60s and 70s